BRICKELL BIOTECH
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell’s executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®.
BRICKELL BIOTECH
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.brickellbio.com
Total Employee:
11+
Status:
Active
Contact:
7865242721
Email Addresses:
[email protected]
Total Funding:
33.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-06-03 | Vical | Vical acquired by Brickell Biotech | N/A |
Investors List
Charlie Stiefel
Charlie Stiefel investment in Series C - Brickell Biotech
AMOREPACIFIC Ventures
AMOREPACIFIC Ventures investment in Series B - Brickell Biotech
Palisade Capital Management
Palisade Capital Management investment in Series B - Brickell Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-01 | Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer |
Official Site Inspections
http://www.brickellbio.com Semrush global rank: 2.28 M Semrush visits lastest month: 8.3 K
- Host name: 172.67.223.96
- IP address: 172.67.223.96
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
